The course of bullous pemphigoid against the background of vaccination against a new coronavirus infection (COVID-19)
The article describes a clinical case of vaccination with the drug "Kovivac" of a patient of an older age group with an established diagnosis of bullous pemphigoid. Scientific data on the prevalence of bullous dermatoses in the Russian Federation (true pemphigus, Lever's bullous pemph...
Main Authors: | Andrey A. Martynov, Anna V. Vlasova |
---|---|
Format: | Article |
Language: | English |
Published: |
State Scientific Center of Dermatovenereology and Cosmetology
2021-10-01
|
Series: | Vestnik Dermatologii i Venerologii |
Subjects: | |
Online Access: | https://vestnikdv.ru/jour/article/viewFile/1244/1221 |
Similar Items
-
Case Report: The many faces of bullous pemphigoid
by: Laura Rechtien, et al.
Published: (2023-10-01) -
Retrospective analysis of autoimmune bullous diseases in Middle Franconia
by: Lukas Sollfrank, et al.
Published: (2023-10-01) -
Quality of life index in autoimmune bullous dermatosis patients
by: Mariana Álvares Penha, et al.
Published: (2015-04-01) -
Blisters and Milia around the Peritoneal Dialysis Catheter: A Case of Localized Bullous Pemphigoid
by: Andrea Michelerio, et al.
Published: (2022-08-01) -
May bullous pemphigoid be worsened by COVID-19 vaccine?
by: Emanuele Cozzani, et al.
Published: (2022-11-01)